MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes

Experimental Cell Research

Volumn 319, Issue 8, 2013, Pages 1165-1175

  Wang, Jie ^a,b   Yan, Cheng Hui ^b   Li, Yang ^b   Xu, Kai ^b   Tian, Xiao Xiang ^b   Peng, Cheng Fei ^b   Tao, Jie ^b   Sun, Ming Yu ^b   Han, Ya Ling ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

Cellular repressor of E1A stimulated genes; MicroRNA; Phenotypic modulation; Vascular smooth muscle cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CALPONIN; CREG PROTEIN; E1A PROTEIN; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 31; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; FEMALE; GAIN OF FUNCTION MUTATION; GENE CONTROL; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN-STENT RESTENOSIS; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MEDIATOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING;

EID: 84876089285     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.03.010     Document Type: Article

References (46)

1. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
2. Kawai-Kowase K., Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2007, 292:C59-69.
3. Schwartz S.M. Perspectives series: cell adhesion in vascular biology Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest. 1997, 99:2814-2816.
4. Rzucidlo E.M., Martin K.A., Powell R.J. Regulation of vascular smooth muscle cell differentiation. J. Vasc. Surg. 2007, 45(Suppl. A):A25-32.
5. Veal E., Eisenstein M., Tseng Z.H., Gill G. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol. Cell. Biol. 1998, 18:5032-5041.
6. Han Y.L., Liu H.W., Kang J., Yan C.H., Wang X.Z., Zhao L.Y., Li S.H. Expression of cellular repressor of E1A-stimulated genes in vascular smooth muscle cells of different phenotypes. Zhonghua Yi Xue Za Zhi 2005, 85:49-53.
7. Han Y., Luan B., Sun M., Guo L., Guo P., Tao J., Deng J., Wu G., Liu S., Yan C., Li S. Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic modulation of vascular smooth muscle cells. J. Mol. Cell. Cardiol. 2011, 50:723-730.
8. Han Y., Wu G., Deng J., Tao J., Guo L., Tian X., Kang J., Zhang X., Yan C. Cellular repressor of E1A-stimulated genes inhibits human vascular smooth muscle cell apoptosis via blocking P38/JNK MAP kinase activation. J. Mol. Cell. Cardiol. 2010, 48:1225-1235.
9. Small T.W., Bolender Z., Bueno C., O'Neil C., Nong Z., Rushlow W., Rajakumar N., Kandel C., Strong J., Madrenas J., Pickering J.G. Wilms' tumor 1-associating protein regulates the proliferation of vascular smooth muscle cells. Circ. Res. 2006, 99:1338-1346.
10. Han Y., Deng J., Guo L., Yan C., Liang M., Kang J., Liu H., Graham A.M., Li S. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Cardiovasc. Res. 2008, 78:597-604.
11. Han Y., Guo L., Yan C., Guo P., Deng J., Mai X., Kang J., Li S. Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury. J. Vasc. Surg. 2008, 48:201-209.
12. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
13. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113:673-676.
14. Farh K.K., Grimson A., Jan C., Lewis B.P., Johnston W.K., Lim L.P., Burge C.B., Bartel D.P. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005, 310:1817-1821.
15. Pasquinelli A.E., Hunter S., Bracht J. MicroRNAs: a developing story. Curr. Opin. Genet. Dev. 2005, 15:200-205.
16. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
17. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
18. Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8:93-103.
19. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 2009, 104:476-487.
20. Cheng Y., Liu X., Yang J., Lin Y., Xu D.Z., Lu Q., Deitch E.A., Huo Y., Delphin E.S., Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 2009, 105:158-166.
21. Viader A., Chang L.W., Fahrner T., Nagarajan R., Milbrandt J. MicroRNAs modulate Schwann cell response to nerve injury by reinforcing transcriptional silencing of dedifferentiation-related genes. J. Neurosci. 2011, 31:17358-17369.
22. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
23. Liu X., Sempere L.F., Ouyang H., Memoli V.A., Andrew A.S., Luo Y., Demidenko E., Korc M., Shi W., Preis M., Dragnev K.H., Li H., Direnzo J., Bak M., Freemantle S.J., Kauppinen S., Dmitrovsky E. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 2010, 120:1298-1309.
24. Cottonham C.L., Kaneko S., Xu L. miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J. Biol. Chem. 2010, 285:35293-35302.
25. Laurila E.M., Sandstrom S., Rantanen L.M., Autio R., Kallioniemi A. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Genes Chromosomes Cancer 2012, 51:557-568.
26. Valastyan S., Weinberg R.A. miR-31: a crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 2010, 9:2124-2129.
27. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
28. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
29. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33:1290-1297.
30. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 2007, 100:1579-1588.
31. Owens G.K. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp. 2007, 283:174-191.
32. Han W.X., Kang YL, Liu J, Li HW SH, The change of cellular repressor of E1A-stimulated genes of vascular smooth muscle cell after balloon injury of rat carotid arteries. Chin. J. Cardiol. 2004, 32:53-58.
33. Han K.J., Zhang YL, Li J SH, Expression of smooth muscle-special molecules and phenotypic changes in HITASY cells by serum withdrawal. Prog. Biochem. Biophys. 2003, 30:868-873.
34. Veal E., Groisman R., Eisenstein M., Gill G. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells. Oncogene 2000, 19:2120-2128.
35. Han YL, Yan CH, Liu HW, Hu Y, Kang J, Wang XZ, Li SH Overexpression of the cellular repressor of E1A-stimulated-genes regulate the rat primary VSMCs differentiation in vitro. Prog. Biochem. Biophys. 2004, 31:1009-1105.
36. Han YL, Xu HM, Yan CH, Hu Y, Kang J, Liu HW The cellular repressor of E1A-stimulated genes promotes human VSMCs differentiation in vitro mediated by RhoA and SRF. Prog. Biochem. Biophys. 2006, 33:438-445.
37. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 2009, 119:2634-2647.
38. Burton C.D., Cardon P.R., Craddock L.R., Deloukas N., Duncanson P., Kwiatkowski A., McCarthy D.P., Ouwehand M.I., Samani W.H., Todd N.J., Donnelly J.A., Barrett P., Burton J.C., Davison P.R., Donnelly D., Easton P., Evans D., Leung D., Marchini H.T., Morris J.L., Spencer A.P., Tobin C.C., Cardon M.D., Clayton L.R., Attwood D.G., Boorman A.P., Cant J.P., Everson B., Hussey U., Jolley J.M., Knight J.D., Koch A.S., Meech K., Nutland E., Prowse S., Stevens C.V., Taylor H.E., Walters N.C., Walker G.R., Watkins N.M., Winzer N.A., Todd T., Ouwehand J.A., Jones W.H., McArdle R.W., Ring W.L., Strachan S.M., Pembrey D.P., Breen M., Clair G., Caesar D., Gordon-Smith S., Jones K., Fraser L., Green C., Grozeva E.K., Hamshere D., Holmans M.L., Jones P.A., Kirov I.R., Moskvina G., Nikolov V., O'Donovan I., Owen M.C., Craddock M.J., Collier N., Elkin D.A., Farmer A., Williamson A., McGuffin R., Young P., Ferrier A.H., Ball I.N., Balmforth S.G., Barrett A.J., Bishop J.H., Iles D.T., Maqbool M.M., Yuldasheva A., Hall N., Braund A.S., Burton P.S., Dixon P.R., Mangino R.J., Suzanne M., Tobin S., Thompson M.D., Samani J.R., Bredin N.J., Tremelling F., Parkes M., Drummond M., Lees H., Nimmo C.W., Satsangi E.R., Fisher J., Forbes S.A., Lewis A., Onnie C.M., Prescott C.M., Sanderson N.J., Mathew J., Barbour C.G., Mohiuddin J., Todhunter M.K., Mansfield C.E., Ahmad J.C., Cummings T., Jewell F.R., Webster D.P., Brown J., Clayton M.J., Lathrop D.G., Connell G.M., Dominczak J., Samani A., Marcano N.J., Burke C.A., Dobson B., Gungadoo R., Lee J., Munroe K.L., Newhouse P.B., Onipinla S.J., Wallace A., Xue C., Caulfield M., Farrall M., Barton M., Bruce A., Donovan I.N., Eyre H., Gilbert S., Hider P.D., Hinks S.L., John A.M., Potter S.L., Silman C., Symmmons A.J., Thomson D.P., Worthington W., Clayton J., Dunger D.G., Nutland D.B., Stevens S., Walker H.E., Widmer N.M., Todd B., Frayling J.A., Freathy T.A., Lango R.M., Perry H., Shields J.R., Weedon B.M., Hattersley M.N., Hitman A.T., Walker G.A., Elliott M., Groves K.S., Lindgren C.J., Rayner C.M., Timpson N.W., Zeggini N.J., McCarthy E., Newport M.I., Sirugo M., Lyons G., Vannberg E., Hill F., Bradbury A.V., L.A.Farrar C.Pointon, Wordsworth J.J., Brown P., Franklyn M.A., Heward J.A., Simmonds J.M., Gough M.J., Seal S.C., Stratton S., Rahman M.R., Ban N., Goris M., Sawcer A., Compston S.J., Conway A., Jallow D., Newport M., Sirugo M., Rockett G., Kwiatowski K.A., Bumpstead D.P., Chaney S.J., Downes A., Ghori K., Gwilliam M.J., Hunt R., Inouye S.E., Keniry M., King A., McGinnis E., Potter R., Ravindrarajah S., Whittaker R., Widden P., Withers C., Deloukas D., Leung P., Nutland H.T., Stevens S., Walker H.E., Todd N.M., Easton J.A., Clayton D., Burton D.G., Tobin P.R., Barrett M.D., Evans J.C., Morris D., Cardon A.P., Cardin L.R., Davison N.J., Ferreira D., Pereira-Gale T., Hallgrimsdottir J., Howie I.B., Marchini B.N., Spencer J.L., Su C.C., Teo Z., Vukcevic Y.Y., Donnelly D., Bentley P., Brown D., Gordon M.A., Caulfield L.R., Clayton M., Compston D.G., Craddock A., Deloukas N., Donnelly P., Farrall P., Gough M., Hall S.C., Hattersley A.S., Hill A.T., Kwiatkowski A.V., Mathew D.P., McCarthy C., Ouwehand M.I., Parkes W.H., Pembrey M., Rahman M., Samani N., Stratton N.J., Todd M.R., Worthington J J.A. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
39. Hamsten A., Eriksson P. Quest for genes and mechanisms linking the human chromosome 9p21.3 locus to cardiovascular disease. Circulation 2012, 126:1815-1817.
40. Helgadottir A., Thorleifsson G., Magnusson K.P., Gretarsdottir S., Steinthorsdottir V., Manolescu A., Jones G.T., Rinkel G.J., Blankensteijn J.D., Ronkainen A., Jaaskelainen J.E., Kyo Y., Lenk G.M., Sakalihasan N., Kostulas K., Gottsater A., Flex A., Stefansson H., Hansen T., Andersen G., Weinsheimer S., Borch-Johnsen K., Jorgensen T., Shah S.H., Quyyumi A.A., Granger C.B., Reilly M.P., Austin H., Levey A.I., Vaccarino V., Palsdottir E., Walters G.B., Jonsdottir T., Snorradottir S., Magnusdottir D., Gudmundsson G., Ferrell R.E., Sveinbjornsdottir S., Hernesniemi J., Niemela M., Limet R., Andersen K., Sigurdsson G., Benediktsson R., Verhoeven E.L., Teijink J.A., Grobbee D.E., Rader D.J., Collier D.A., Pedersen O., Pola R., Hillert J., Lindblad B., Valdimarsson E.M., Magnadottir H.B., Wijmenga C., Tromp G., Baas A.F., Ruigrok Y.M., van Rij A.M., Kuivaniemi H., Powell J.T., Matthiasson S.E., Gulcher J.R., Thorgeirsson G., Kong A., Thorsteinsdottir U., Stefansson K. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 2008, 40:217-224.
41. Gschwendtner A., Bevan S., Cole J.W., Plourde A., Matarin M., Ross-Adams H., Meitinger T., Wichmann E., Mitchell B.D., Furie K., Slowik A., Rich S.S., Syme P.D., MacLeod M.J., Meschia J.F., Rosand J., Kittner S.J., Markus H.S., Muller-Myhsok B., Dichgans M. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann. Neurol. 2009, 65:531-539.
42. Bishop D.T., Demenais F., Iles M.M., Harland M., Taylor J.C., Corda E., Randerson-Moor J., Aitken J.F., Avril M.F., Azizi E., Bakker B., Bianchi-Scarra G., Bressac-de Paillerets B., Calista D., Cannon-Albright L.A., Chin A.W.T., Debniak T., Galore-Haskel G., Ghiorzo P., Gut I., Hansson J., Hocevar M., Hoiom V., Hopper J.L., Ingvar C., Kanetsky P.A., Kefford R.F., Landi M.T., Lang J., Lubinski J., Mackie R., Malvehy J., Mann G.J., Martin N.G., Montgomery G.W., van Nieuwpoort F.A., Novakovic S., Olsson H., Puig S., Weiss M., van Workum W., Zelenika D., Brown K.M., Goldstein A.M., Gillanders E.M., Boland A., Galan P., Elder D.E., Gruis N.A., Hayward N.K., Lathrop G.M., Barrett J.H., Bishop J.A. Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 2009, 41:920-925.
43. Melzer D., Frayling T.M., Murray A., Hurst A.J., Harries L.W., Song H., Khaw K., Luben R., Surtees P.G., Bandinelli S.S., Corsi A.M., Ferrucci L., Guralnik J.M., Wallace R.B., Hattersley A.T., Pharoah P.D. A common variant of the p16(INK4a) genetic region is associated with physical function in older people. Mech. Ageing Dev. 2007, 128:370-377.
44. McDonald O.G., Owens G.K. Programming smooth muscle plasticity with chromatin dynamics. Circ. Res. 2007, 100:1428-1441.
45. Wamhoff B.R., Lynch K.R., Macdonald T.L., Owens G.K. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1454-1461.
46. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:812-819.